Shanghai Hile Bio-Technology Co., Ltd.
SHH: 603718.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Benyi Han
- Employees
- 366
- Headquarters
- Shanghai, China
- IPO year
- 2015
- Market cap
- CN¥2.4B
- Website
- https://www.hile-bio.com
Loading 603718…
Loading profile data…Frequently asked questions about 603718
What does Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) do?
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of p...
Where does 603718.SS trade?
Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) trades on the Shanghai Stock Exchange.
What sector is 603718.SS in?
Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai Hile Bio-Technology Co., Ltd.?
Benyi Han is the chief executive officer of Shanghai Hile Bio-Technology Co., Ltd. (603718.SS).
Where is Shanghai Hile Bio-Technology Co., Ltd. headquartered?
Shanghai Hile Bio-Technology Co., Ltd. is headquartered in China.
Does 603718.SS pay a dividend?
Yes — Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) paid a trailing twelve-month dividend of CNY 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603718.SS go public?
Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) completed its initial public offering in 2015.